当然药明康德可以证明了市场信心是正确的。
相比之下,药明康德为大部分的国际制药巨头提供药品外包研发服务。
WuXi, by contrast, provides outsourced research for most of the world's big drug companies.
但无锡药明康德自2004年以来营收增长了10倍以上,因此很可能将成为销售增长的推动力。
But Wuxi, which has seen revenue increase more than 10-fold since 2004, is likely to drive growth.
应用推荐